Biotech and pharma companies hire Pharmagellan when their own teams are stretched too thin to realize the full value of their R&D portfolios.

Pharmagellan fills the gap with wide-ranging expertise – from designing biomarker strategies and clinical trials, to assessing market opportunities and building financial models, to presenting before your board or portfolio review committee. That breadth of ability allows us to adapt as your needs grow and your pipeline progresses.

Pharmagellan is a rarity among biotech consultants: a firm that thinks big picture but also executes the specifics.



  • IND-enabling preclinical data analysis

  • Translational science and biomarker strategy

  • Next-gen sequencing and immuno-oncology strategy, execution, and outsourcing

  • Patient selection and sample handling logistics

  • Clinical development strategy and trial design

  • Collaborator identification and engagement

+ CorporatE

  • Opportunity assessment
  • Forecasting and valuation

  • Pipeline prioritization

  • M&A/partnering strategy and execution support

  • Due diligence and in-licensing support

  • Competitive intelligence and positioning

  • Alternate commercial and financing models